Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: experience in four cases.
The treatment of renal limited systemic vasculitis usually involves a combination of cytotoxic drugs and steroids. As shown by randomised prospective controlled trial, plasmapheresis may be of additional benefit for the management of patients with renal involvement severe enough to require dialysis...
Main Authors: | Elliott, J, Lockwood, C, Hale, G, Waldmann, H |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
1998
|
פריטים דומים
-
Monoclonal-antibody therapy in systemic vasculitis.
מאת: Mathieson, P, et al.
יצא לאור: (1990) -
MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS
מאת: Mathieson, P, et al.
יצא לאור: (1990) -
HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
מאת: Lockwood, C, et al.
יצא לאור: (1993) -
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
מאת: Lockwood, C, et al.
יצא לאור: (1993) -
MONOCLONAL-ANTIBODIES IN SYSTEMIC VASCULITIS - LONG-TERM BENEFIT FROM SHORT-TERM THERAPY
מאת: Isaacs, J, et al.
יצא לאור: (1993)